KRAS and neoplasm: The survival outcomes were similar among users regardless of K-Ras mutation.320 Similarly, other clinical trials in advanced gastric cancer patients found that the addition of simvastatin or pravastatin to chemotherapy does not improve survival outcomes.321,322 In conclusion, careful consideration of tumour specificity and indications, as well as multiple pharmacological properties, is needed before applying statins in the clinical treatment of cancer.